Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$635K Sell
11,726
-3,867
-25% -$204K 0.1% 227
2016
Q1
$790K Buy
15,593
+9,385
+151% +$467K 0.08% 257
2015
Q4
$313K Sell
6,208
-2,251
-27% -$115K 0.03% 428
2015
Q3
$407K Sell
8,459
-244
-3% -$12.7K 0.05% 343
2015
Q2
$453K Sell
8,703
-303
-3% -$17.1K 0.05% 352
2015
Q1
$519K Buy
9,006
+190
+2% +$10.9K 0.06% 336
2014
Q4
$471K Buy
8,816
+4
+0% +$224 0.05% 335
2014
Q3
$506K Buy
8,812
+5,307
+151% +$325K 0.06% 324
2014
Q2
$234K Buy
+3,505
New +$237K 0.03% 492

Other funds holding GSK

VSR Financial Services's GSK Position: Q2 2016 in Review

VSR Financial Services reduced its GSK (GSK) stake by 25% in Q2 2016, selling an estimated $204K and leaving 11,726 shares worth $635K. The position accounts for 0.1% of the portfolio, ranked #227.

VSR Financial Services first reported a position in GSK in Q2 2014 and has held it in 9 quarters since. The position peaked at $790K in Q1 2016. 741 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

  • VSR Financial Services held 11,726 shares of GSK worth $635K as of Q2 2016.
  • VSR Financial Services sold 3,867 GSK shares in Q2 2016, an estimated $204K.
  • GSK made up 0.1% of VSR Financial Services's portfolio in Q2 2016, its #227 holding.
  • VSR Financial Services first reported a position in GSK in Q2 2014 and has held it in 9 quarters since.
  • VSR Financial Services's GSK position peaked at $790K in Q1 2016.
  • 741 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on VSR Financial Services's 13F filing for Q2 2016, filed 11 Aug 2016.